Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation

Arsenic trioxide (As(2)O(3)) is one of the most effective therapeutic agents used for patients with acute promyelocytic leukemia (APL). The probable explanation for As(2)O(3)-induced cell differentiation is the direct targeting of PML-RARα oncoprotein by As(2)O(3), which results in initiation of PML...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qian Qian, Zhou, Xin Yi, Zhang, Yan Fang, Bu, Na, Zhou, Jin, Cao, Feng Lin, Naranmandura, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694856/
https://www.ncbi.nlm.nih.gov/pubmed/26213848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694856/
https://www.ncbi.nlm.nih.gov/pubmed/26213848

Ejemplares similares